Beleodaq is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Spectrum Pharmaceuticals, Inc.. The primary component is Belinostat.
| Product ID | 68152-108_8361737e-fcce-4a93-97ca-1220b1132979 |
| NDC | 68152-108 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Beleodaq |
| Generic Name | Belinostat |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-07-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206256 |
| Labeler Name | Spectrum Pharmaceuticals, Inc. |
| Substance Name | BELINOSTAT |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2014-07-21 |
| Marketing End Date | 2022-11-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206256 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-07-21 |
| Ingredient | Strength |
|---|---|
| BELINOSTAT | 500 mg/10mL |
| SPL SET ID: | 84b2e16e-f0d1-4757-8da8-79dfa83aab79 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68152-108 | Beleodaq | Belinostat |
| 69605-002 | Beleodaq | Belinostat |
| 72893-002 | Beleodaq | Belinostat |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BELEODAQ 86140026 4626277 Live/Registered |
ACROTECH BIOPHARMA LLC 2013-12-10 |